<DOC>
	<DOCNO>NCT01650714</DOCNO>
	<brief_summary>The propose study ass efficacy safety innovative endoscopic technique acquisition full thickness gastric muscle wall biopsy . Having access full thickness biopsy allow increase understanding pathophysiology gastrointestinal disease functional gastrointestinal disorder , gastroparesis , pseudoobstruction motility disorder . This information essential development target effective therapy currently available . Despite high prevalence functional gastrointestinal disorder significant impact social health care cost , underlie cause well understood effective specific treatment successfully alleviate patient symptom .</brief_summary>
	<brief_title>Endoscopic Full Thickness Biopsy , Gastric Wall .</brief_title>
	<detailed_description>Our group study new endoscopic method use submucosal endoscopy mucosal flap ( SEMF ) technique acquire full thickness gastric tissue successfully safely preclinical study . The propose study ass efficacy safety innovative endoscopic technique acquisition full thickness gastric muscle wall biopsy . Having access full thickness biopsy allow increase understanding pathophysiology gastrointestinal disease functional gastrointestinal disorder , gastroparesis , pseudoobstruction motility disorder . This information essential development target effective therapy currently available . Despite high prevalence functional gastrointestinal disorder significant impact social health care cost , underlie cause well understood effective specific treatment successfully alleviate patient symptom .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>1 . Symptomatic refractory idiopathic gastroparesis : 1 . The refractory nature symptom ( e.g . base nutritional failure , consideration enteral parenteral nutrition ) determine physician/gastroenterologist primary care provider patient 's gastroparesis . 2 . Patients documentation within last 2 year delay gastric empty &gt; 30 % retain gastric content 4 hour base 296 kcal solidliquid , fatcontaining standard meal gastric empty test . 3 . The patient 's physician determine procedure may potentially provide prognostic therapeutic option . 2 . Age &gt; 18 &lt; 70 year old 3 . Hemoglobin ( Hb ) &gt; 10g , platelet &gt; 150,000 prothrombin time international normalize ratio ( INR ) &lt; 1.5 4 . Ability give inform consent 1 . Prior oropharyngeal , esophageal , gastric small bowel surgery 2 . Esophageal stricture 3 . Prior abdominal radiation therapy 4 . Prior feed tube placement 5 . Coagulopathy 6 . Use Coumadin antiplatelet drug e.g . Plavix , steroid immunosuppressive drug 7 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>